/en/sysglobalassets/global-assets/capabilities/lens_thick_light.svg

Healthcare Innovation

Investing in the world’s health

Our approach

The strategy

The team

Insights

Across the world, we are living longer – this is due to rapid advances in healthcare science, new procedures and better use of data science and computing power. At the same time, an increasing focus on healthy living and improved well-being has never been more in the spotlight. 2020 has definitely been a significant year for healthcare innovation, changing its landscape forever.

Although traditionally seen as a source of relatively defensive growth, the rapid pace of change across the healthcare sector are opening up a new world of healthcare investment opportunities.

Introduction to healthcare innovation

Find out about the drivers behind longer, healthier lives.

An exciting time for healthcare

John Bowler, Global Healthcare portfolio manager shares his insight

Schroder Healthcare Innovation Strategy

A portfolio that gives investors a broad exposure to companies shaping the world of healthcare

About the strategy

Schroder Healthcare Innovation team

A quick overview of the team behind Schroder Healthcare Innovation

Meet the team

What are the long-term prospects for healthcare investing post Covid-19?

The pandemic has shone a spotlight on healthcare but what happens when a vaccine is found? We asked Schroders’ investment experts for their views on the sector’s long-term prospects.

Tell me more

Latest Healthcare Innovation articles

Risk Considerations:

All investments involve risks, including the risk of possible loss of principal. The market value of the portfolio may decline as a result of a number of factors, including adverse economic and market conditions, prospects of stocks in the portfolio, changing interest rates, and real or perceived adverse competitive industry conditions. Investing overseas involves special risks including among others, risks related to political or economic instability, foreign currency (such as exchange, valuation and fluctuation) risk, market entry or exit restrictions, illiquidity and taxation. These risks exist to a greater extent in emerging markets than in developed markets.

The portfolio may be concentrated in a limited number of geographical regions, industry sectors, markets and/or individual positions. This may result in large changes in the value of the fund, both up or down.

The portfolio may have contractual agreements with counterparties. If a counterparty is unable to fulfil their obligations, the sum that they owe to the fund may be lost in part or in whole.

The portfolio may lose value as a result of movements in foreign exchange rates.

Derivatives may be used to manage the portfolio efficiently. A derivative may not perform as expected, may create losses greater than the cost of the derivative and may result in unlimited loss.

The transition of the financial markets away from the use of interbank offered rates (IBORs) to alternative reference rates may impact the valuation of certain holdings and disrupt liquidity in certain instruments. This may impact the investment performance of the portfolio.

In difficult market conditions, securities may not be able to be sold for full value or at all. This could affect performance and could cause the fund to defer or suspend redemptions of its shares.

The value of investments can go up and down and an investor may not get back the amount initially invested.

Failures at service providers could lead to disruptions of portfolio management operations or losses.

Investment objectives express an intended result but there is no guarantee that such a result will be achieved. Depending on market conditions and the macro economic environment, investment objectives may become more difficult to achieve.

These are not a comprehensive list of risks. Please see prospectus for more risk disclosures.

Contact Schroders

Schroders is a world-class asset manager operating from 37 locations across Europe, the Americas, Asia and the Middle East.

Worldwide locations

Our sales team is available to discuss with you any investment options and opportunities you might be interested in. For any further questions, please contact us.

For Press inquiries or any media relations questions, please contact us.

Media Contacts

Please consider a fund's investment objectives, risks, charges and expenses carefully before investing. To obtain this and other information on any Schroders Fund, please click the following link: prospectuses. Read the prospectus carefully before investing. To obtain any further information call your financial advisor or call Schroder Mutual Funds at (800) 464-3108 for Individual Investors.

Schroder Investment Management North America Inc. (“SIMNA”) is an SEC registered investment adviser providing asset management products and services to clients in the US and Canada. SIMNA is an indirect wholly owned subsidiary of Schroders plc, a UK public company with shares listed on the London Stock Exchange. Schroder Fund Advisors LLC (“SFA”) is a wholly-owned subsidiary of SIMNA Inc. and is registered as a limited purpose broker-dealer with FINRA and markets certain investment vehicles for which for which another Schroders entity is an investment adviser. The Schroder mutual funds (the “Funds”) are distributed by SEI Investments Distribution Co (“SIDCO”), a member of FINRA. SFA previously served as the distributor of the Funds. Although SFA has been replaced by SIDCO as the distributor of the Funds, SFA continues to be involved in the distribution of shares of the Funds through an agreement with SIDCO, and SFA, SIMNA and their affiliates continue to provide shareholder services to the Funds. SIDCO is not an affiliate of Schroders plc.

Beginning June 2021, Schroder Adveq, Schroder Secquaero and other Schroders private equity brands will transition under and be known as Schroders Capital. Schroders Capital will be the private markets investment division of Schroders plc. Schroder Adveq Management US Inc. (“Schroder Adveq US” or “Schroder Adveq” herein) is registered as an investment adviser with the SEC. It provides asset management products and services to clients in the United States and Canada.

Schroder Secquaero (formerly Secquaero Advisors AG) is Zurich-based and provides non-discretionary advice to certain strategies, including Insurance-linked securities, marketed in North America.

Schroder Adveq and Schroder Secquaero, currently known as Schroders Capital, are wholly-owned subsidiary of Schroders plc. For more information, visit www.schroder.com

Select a region

Select a location

Select a site

Retail Investors

Retirement Services

Mutual fund investment

Private Investor

Real Estate

Asset management

Wealth management

Select a region

Select a location

Select a site

Retail Investors

Retirement Services

Mutual fund investment

Private Investor

Real Estate

Asset management

Wealth management

Schroders in the US

Schroders Globally

Latest News

Outlook 2022: Global convertible bonds

Outlook 2022: Global cities

Healthcare Innovation

Investing in the world’s health

Introduction to healthcare innovation

An exciting time for healthcare

What are the long-term prospects for healthcare investing post Covid-19?

Latest Healthcare Innovation articles

Risk Considerations:

Contact Schroders

Select a region

Select a location

Select a site

Retail Investors

Retirement Services

Mutual fund investment

Private Investor

Real Estate

Asset management

Wealth management

Select a region

Select a location

Select a site

Retail Investors

Retirement Services

Mutual fund investment

Private Investor

Real Estate

Asset management

Wealth management

Schroders in the US

Schroders Globally

Latest News

Outlook 2022: Global convertible bonds

Outlook 2022: Global cities

Global Investor Study

Schroders Global Investor Study 2021

Schroders Institutional Investor Study

View the results

Related Search

Healthcare Innovation

Investing in the world’s health

Introduction to healthcare innovation

An exciting time for healthcare

What are the long-term prospects for healthcare investing post Covid-19?

Latest Healthcare Innovation articles

Risk Considerations:

Contact Schroders